CompoAtlas

Beauty & Hair

Food supplement declared in France, declaration No 2023-7-830, decision dated 18 July 2023

Beauty & Hair (RINGANA) is a food supplement declared in France. Status: declared in France, may be marketed. None of the rules we check flags an issue with its declared composition.

Brand
RINGANA
Food business operator placing the product on the market
RINGANA GmbH
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Capsule
Daily dose
3 gélules
Directions for use
3 gélules par jour, avaler de préférence au cours des repas avec un peu d'eau
Intended populations
Men, Women
Not recommended (according to the manufacturer)
Breastfeeding women, Pregnant women
Objectives stated by the manufacturer (these are not authorised claims)
Skin, Hair and nails

Declaration 197777, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Fagopyrum esculentum MoenchGermePoudre (de plantes séchées ou broyées)165 mg
Malus domestica BorkhFruitExtrait sec hydroalcoolique150 mg
Malpighia glabra L.FruitPoudre (de plantes séchées ou broyées)141 mg
Pisum sativum L.GermeExtrait sec hydroalcoolique100 mg
Ajuga reptans L.Parties aériennesExtrait sec hydroalcoolique75 mg
Sambucus nigra L.FruitExtrait sec hydroalcoolique50 mg
Cucumis melo L.FruitAutre extrait fluide40 mg
Triticum aestivum L.GraineExtrait sec alcoolique30 mg

Other active ingredients

NamePer day
Carnosinenot declared
Hyaluronate de sodiumnot declared

Additives

E903, E464

Other ingredients

Cyamopsis tetragonoloba (L.) Taub., maltodextrine

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Label warnings

La dose journalière indiquée ne doit pas être dépassée. Les compléments alimentaires ne peuvent être utilisés comme substituts d’un régime alimentaire varié et équilibré et d’un mode de vie sain. Ce produit a été conçu pour des adultes et doit être tenu hors de la portée des jeunes enfants.Les gélules RINGANA CAPS ne sont pas des médicaments et ne remplacent pas la consultation d’un médecin. Les gélules RINGANA CAPS ne sont pas destinées à soigner ou traiter des maladies. Si vous suivez un traitement médical ou souffrez de problèmes de santé, consultez votre médecin avant toute utilisation des gélules RINGANA CAPS. Ne pas utiliser pendant la grossesse et l’allaitement.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Sambucus nigra L.
    Read the warning, when it applies and the studies cited

    ELDER – SAMBUCUS

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Condition of application: Diaphoretic; Symptoms of colds, flus; Sinusitis, hay-fever; Joint pain.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Known adverse reactions

    Condition of application: All products.

    Stop use if hypersensitivity/allergy occur (Forster-Waldl et al. 2003).

    Sources cited by Health Canada (1)
    • Förster-Waldl E, Marchetii M, Schöll I, Focke M, Radauer C, Kinaciyan T, Nentwich I, Jäger S, Schmid ER, Boltz-Nitulescu G, Scheiner O, Jensen-Jarolim E. Type I allergy to elderberry (Sambucus nigra) is elicited by a 33.2 kDa allergen with significant homology to ribosomal inactivating proteins. Clinical and Experimental Allergy 2003;33(2):1703-1710. PubMed

    Condition of application: All products except those making a diuretic claim.

    When using this product diuretic effect may occur (Bradley 1992; Winston and Kuhn 2008; Barnes et al. 2007; Hoffman 2003).

    Sources cited by Health Canada (2)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines. 3rd edition. London (GB): The Pharmaceutical Press; 2007.
    • Winston D and Kuhn MA. Herbal Therapy & Supplements A Scientific and Traditional Approach. Philadelphia (PA): Lippincott Williams & Wilkins; 2008.

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 19 December 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Brand : RINGANA

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

List recorded in 2023. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line